SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Merck
MRK 110.08-0.8%11:59 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Brian Malloy who wrote (487)1/21/1998 3:53:00 PM
From: tommysdad  Read Replies (1) of 1580
 
<<MRK tends not to have drugs pulled from the market once appproved as was the case with a Pfizer
drug last year that was a newly vauted drug to help with diabetes. Unfortunately, it appeared that in the
real world it was causing too much liver damage and a few deaths. The FDA pulled it.>>

Umm, wrong company, wrong conclusion. WLA has a diabetes drug, Rezulin, currently on the market that now has a new warning label due to liver damage being observed, but the FDA didn't "pull it", it's still marketed. And PFE was not involved.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News